ClinicaliQ Trial Snapshot
- Personalised Ablation Strategies in AF — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT05633303.
- What is being tested: Personalised ablation strategies for atrial fibrillation that move beyond standard one-size-fits-all approaches to customise treatment based on individual patient characteristics and AF substrate.
- Patient eligibility overview: Adults with atrial fibrillation suitable for catheter ablation, with the trial likely including both paroxysmal and persistent AF patients stratified by baseline clinical and anatomical features.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Atrial fibrillation (AF) is the most common arrhythmia with an expected rise in prevalence over the next decade. Catheter ablation is a safe treatment option in eliminating AF however, success rates still remains variable. Existing strategies do not take into account the differences in AF perpetuation mechanisms beyond the pulmonary veins (PVs) due to the underlying substrate. Here, I will investigate the differences in persistent AF mechanisms due to the underlying substrate and utilise these findings to generate AF mechanism specific ablation strategies. I have defined a new metric, rate-dependent…
Eligibility Snapshot
- : * Patients undergoing catheter ablation for persistent AF (
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.